"Use of CBD in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials"

CBD has received a great scientific interest thanks to its medical applications. 

In recent years, the scientific community has shown interest in this compound also due to its good safety profile and neuroprotective properties  in several neurodegenerative diseases.

CBD also generating interest due to its therapeutic properties such as antidepressant, antipsychotic, analgesic, and antitumor. 


In addition, it has been shown that CBD can significantly reduce two important forms of anxiety, namely obsessive-compulsive disorder and post-traumatic stress disorder.

CBD shows anti-inflammatory properties in several experimental studies, modulating some pro-inflammatory cytokines and tumor necrosis factor as well as regulation of cell cycle and immune cells’ functions

Moreover, for a long time, the CBD has been investigated for its anticonvulsant effects. Several studies confirmed its efficacy in the treatment of epileptic seizures, especially in pediatric age. In 2016, the first results of  clinical trials showed beneficial effects of CBD in treatment-resistant seizure disorders, including Lennox-Gastaut Syndrome (LGS) and Dravet syndromes (DS).

The purpose of this paper wich published in  12 April 2019 from the 'Molecules Open Access Journals' is to evaluate the use of CBD, in addition to common anti-epileptic drugs, in the severe treatment-resistant epilepsy through an overview of recent literature and clinical trials aimed to study the effects of the CBD treatment in different forms of epilepsy. 

The results of scientific studies obtained so far the use of CBD in clinical applications could represent hope for patients who are resistant to all conventional anti-epileptic drugs.

Cannabis and endocannabinoid modulators: Therapeutic promises and challenges

The discovery that botanical cannabinoids such as THC exert some of their effect through binding specific cannabinoid receptor sites,has led to the discovery of the Endocannabinoid Signaling System, which in turn has spurred research into the mechanisms of action and addiction potential of cannabis.

This paper reviews current understanding of CB1, CB2, and other possible cannabinoid receptors, their arachidonic acid derived ligands (e.g. anandamide 2 arachidonoyl glycerol), and their possible physiological roles. CB1 is heavily represented in the central nervous system, but is found in other tissues as well CB2 tends to be localized to immune cells. Activation of the endocannabinoid system can result in enhanced or dampened activity in various neural circuits depending on their own state of activation.

This suggests that one function of the endocannabinoid system may be to maintain steady state. The therapeutic action of botanical cannabis or of synthetic molecules that are agonists, antagonists, or which may otherwise modify endocannabinoid metabolism and activity indicates they may have promise as neuroprotectants, and may be of value in the treatment of certain types of pain, epilepsy, spasticity, eating disorders, inflammation, and possibly blood pressure control.

"Study Concluded That CBD Can Help With The Reduction of Breast Cancer Cell Proliferation, Invasion and Metastasis"

The process of metastasis to other tissues of the body is the final and fatal step during cancer progression and is the least understood genetically. 

Despite all currently available treatments, breast cancer is most often incurable once clinically apparent metastases develop.

There is a general consensus in the field of cancer research that targeting multiple pathways that control tumor progression is the best strategy for the eradication of aggressive cancers

It is well known that CBD can modulate specific functions of the immune system and the immune system has an important role in the inhibition of cancer progression.

It was essential to determine whether CBD demonstrates antitumor activity and since CBD has a low toxicity, it would be an ideal candidate for use in combination treatments with additional drugs already used in the clinic. 

"Neuroprotective Effects Of Cannabis" by Sensi Seed

Following on from our recent article on the relationship between cannabis use and stroke, we now investigate the role of cannabinoids in mitigating brain damage caused by traumatic brain injury and ischemic stroke. There is mounting evidence to suggest that their various properties have great therapeutic potential.

-Antioxidative & anti-inflammatory properties

In recent years the evidence for the antioxidative and anti-inflammatory properties of various cannabinoids has become well-established, and our understanding of the role they play in modulating neurotransmission too has grown. Thus, serious consideration is now being given to their potential as neuroprotective agents. Cannabinoids have been shown to prevent neuronal death in acute neuronal injury, including Ischemic Stroke (IS) and Traumatic Brain Injury (TBI), as well as provide symptomatic relief in Multiple Sclerosis (MS), Huntington’s disease, and other chronic neurodegenerative diseases.

"Study Reveals That CBD Reduces Blood Pressure After One Dose"

Preclinical studies show CBD has numerous cardiovascular benefits, including a reduced Blood Pressure (BP) response to stress.

The aim of this study from scientists at Nottingham University was to investigate if and how CBD reduces Blood Pressure (BP) in humans.

In June 2017, scientists at Nottingham University published the research they had conducted earlier in the year. Nine healthy male volunteers were given 600 mg of CBD or placebo in a randomized, placebo-controlled, double-blind, crossover study.

CBD was administered in a singular dose after which the research team monitored changes in blood pressure, stroke volume (the measurement of blood that is pumped from the heart’s left ventricle) and heart rate.

All of the study’s participants took part in an exercise test and another stress test using cold temperatures. This allowed researchers to measure cardiac responses under different circumstances.